UGCG
Basic information
Region (hg38): 9:111896814-111935369
Links
Phenotypes
GenCC
Source:
- ichthyosis (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGCG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | 10 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 0 | 0 |
Variants in UGCG
This is a list of pathogenic ClinVar variants found in the UGCG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-111914619-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
9-111914647-T-TA | Congenital nonbullous ichthyosiform erythroderma | Conflicting classifications of pathogenicity (Feb 09, 2023) | ||
9-111914651-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
9-111914663-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
9-111914709-A-G | not specified | Uncertain significance (Jun 30, 2023) | ||
9-111922895-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
9-111926465-A-G | not specified | Uncertain significance (Mar 14, 2023) | ||
9-111929545-G-T | not specified | Uncertain significance (Dec 20, 2023) | ||
9-111931329-A-G | not specified | Uncertain significance (Aug 04, 2023) | ||
9-111932245-T-A | not specified | Uncertain significance (Mar 31, 2023) | ||
9-111932959-C-T | not specified | Uncertain significance (Jan 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UGCG | protein_coding | protein_coding | ENST00000374279 | 9 | 38604 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.941 | 0.0585 | 125736 | 0 | 6 | 125742 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.74 | 101 | 214 | 0.473 | 0.0000103 | 2590 |
Missense in Polyphen | 11 | 56.61 | 0.19431 | 709 | ||
Synonymous | -0.636 | 79 | 72.1 | 1.10 | 0.00000361 | 731 |
Loss of Function | 3.78 | 3 | 22.2 | 0.135 | 0.00000122 | 252 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000120 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the first glycosylation step in glycosphingolipid biosynthesis, the transfer of glucose to ceramide. May also serve as a "flippase". {ECO:0000269|PubMed:8643456}.;
- Pathway
- Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Gaucher Disease;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy (MLD);Fabry disease;Krabbe disease;Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;IL2 signaling events mediated by PI3K
(Consensus)
Recessive Scores
- pRec
- 0.400
Intolerance Scores
- loftool
- 0.215
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.76
Haploinsufficiency Scores
- pHI
- 0.185
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ugcg
- Phenotype
- growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- glucosylceramide biosynthetic process;glycosphingolipid metabolic process;glycosphingolipid biosynthetic process;epidermis development
- Cellular component
- Golgi membrane;membrane;integral component of membrane
- Molecular function
- ceramide glucosyltransferase activity;dihydroceramide glucosyltransferase activity